Speaker illustration

Professor Adrian Paul Banning

John Radcliffe Hospital, Oxford (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
EAPCI

Professor Banning was appointed Consultant Cardiologist in 1999. He then became the Clinical Lead for cardiac medicine and in 2010 was appointed Divisional Director at Oxford University Hospital NHS Trust. He is the first Professor of Interventional Cardiology at Oxford University Professor Banning’s practice, cover a wide range of coronary conditions and procedures. He has championed the use of coronary stents as an alternative to coronary bypass and has been a leading investigator in most of the practice changing trials- Syntax, Excel, Syntax 2 , Noble. He is an expert in left main coronary stenting, bifurcation procedures and optimizing revascularisation in STEMI and multivessel disease.

SYNTAX II trial: five year follow-up

Event: ESC Congress 2021 - The Digital Experience

Topic: Percutaneous Coronary Intervention (PCI)

Session: Trial Updates in ACS & PCI

Thumbnail

Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions.

Event: ESC Congress 2021 - The Digital Experience

Topic: Valvular Heart Disease

Session: Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions

Thumbnail

PCI for left main revascularisation: pro.

Event: ESC Congress 2021 - The Digital Experience

Topic: Interventional Cardiology

Session: Great Debate: controversies in left main revascularisation – to stent or to operate?

Thumbnail

Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions.

Event: ESC Congress 2021 - The Digital Experience

Topic: Valvular Heart Disease

Session: Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions

Thumbnail

Complex coronary disease: CABG or PCI?

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Percutaneous Coronary Intervention (PCI)

Session: Revascularization Strategies in Acute and Chronic Coronary Syndromes: the Latest Update

Thumbnail

Left main is no longer a surgical domain - Rebuttal PRO.

Event: ESC CONGRESS 2017

Topic: Coronary artery bypass surgery

Session: Left main is now a domain of interventional cardiology

Thumbnail

Left main is no longer a surgical domain - PRO

Event: ESC CONGRESS 2017

Topic: Coronary artery bypass surgery

Session: Left main is now a domain of interventional cardiology

Thumbnail

This platform is supported by

logo Novo Nordisk